{"url_path":"/sec/vani/8-k/2026-05-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000854-index.html","accession_number":"0001753926-26-000854","cik":"0001266806","ticker":"VANI","issuer_name":"Vivani Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000854-index.html","primary_entity_key":"0001266806","primary_entity_name":"Vivani Medical, Inc."},"word_count":129,"has_tables":true,"body_markdown":"Item 2.02 Results of Operations and Financial Condition.\n\n \n\nOn May 13, 2026, Vivani Medical, Inc. (the “Company”) issued a press release entitled “Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update” which is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein.\n\n \n\nThe information contained in this Item 2.02 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by reference in such a filing."}